Everyone makes mistakes, but when scientists do, the remedy goes far beyond saying you’re sorry. Two fresh examples show how some journals and universities react when the need arises to set the record straight.
You are here
By Marilynn Marchione The Associated Press
CHICAGO — Most women with the most common form of early-stage breast cancer can safely skip chemotherapy without hurting their chances of beating the disease, doctors are reporting from a landmark study that used genetic testing to gauge each patient’s risk.
CHICAGO — For the first time, a treatment that boosts the immune system greatly improved survival in people newly diagnosed with the most common form of lung cancer. It’s the biggest win so far for immunotherapy, which has had much of its success until now in less common cancers.
There may be a critical window for overweight kids to get to a healthy level. Those who shed their extra pounds by age 13 had the same risk of developing diabetes in adulthood as others who had never weighed too much, a large study of Danish men found.
Trouble is brewing for coffee lovers in California, where a judge ruled that sellers must post scary warnings about cancer risks. But how frightened should we be of a daily cup of joe? Not very, some scientists and available evidence seem to suggest.
Scientific concerns about coffee have eased in recent years, and many studies even suggest it can help health.
ORLANDO, Fla. — A newer cholesterol drug, used with older statin medicines, modestly lowered heart risks and deaths in a big study of heart attack survivors that might persuade insurers to cover the pricey treatment more often.
ORLANDO, Fla. — Trim your hair, your beard, your blood pressure? Black men reduced one of their biggest medical risks through a novel project that shows the power of familiar faces and trusted places to improve health.
Save your life but harm your heart? Health experts are sounding a warning as potential side effects of a growing number of breast cancer treatments come to light.
Scientists are reporting progress on a blood test to detect many types of cancer at an early stage, including some of the most deadly ones that lack screening tools now.
Many groups are working on liquid biopsy tests, which look for DNA and other things that tumors shed into blood, to try to find cancer before it spreads, when chances of cure are best.
A blood test five years after breast cancer treatment helped identify some women who were more likely to relapse, long before a lump or other signs appeared, a preliminary study found.